Regal Investment Advisors LLC Cytosorbents Corp Transaction History

Regal Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.86 - $1.07 $29,510 - $36,717	-34,315 Reduced 74.88%	11,509 $10,000
Q4 2023 Feb 14, 2024	BUY	$1.08 - $1.94 $24,854 - $44,645	23,013 Added 100.89%	45,824 $50,000
Q3 2023 Nov 13, 2023	BUY	$1.86 - $4.03 $6,775 - $14,681	3,643 Added 19.01%	22,811 $42,000
Q2 2023 Aug 11, 2023	BUY	$2.37 - $3.65 $12,167 - $18,739	5,134 Added 36.58%	19,168 $68,000
Q1 2023 May 11, 2023	BUY	$1.79 - $4.17 $25,120 - $58,521	14,034 New	14,034 $47,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.